FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial - Earth News Report
In this articleBIIB4523.T-JPFollow your favorite stocksCREATE FREE ACCOUNT MRI image of brain showing area of Alzheimer patient.Getty Images The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from Biogen and its Japanese partner Eisai to receive an early green light in less than two years. The
